CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BAYER

BAYRY
$42.48B
Large Cap
NASDAQHealthcare🇩🇪Europe88.5K employees

Drugs in Pipeline

350

Phase 3 Programs

207

Upcoming Catalysts

5

Next Catalyst

Next month

Market Overview

Stock performance and key metrics

BAYRY News
Catalyst Timeline

5 upcoming, 0 past

Drug Pipeline

Gadobutrol (Gadavist, Gadovist, BAY86-4875)

Phase 3

Vascular Diseases

Finerenone (Kerendia, BAY94-8862)

Phase 3

Chronic Kidney Disease

Oxybutynin (Oxytrol, BAY839380)

Phase 3

Overactive Bladder

Amikacin Inhalation Solution (BAY41-6551)

Phase 3

Pneumonia, Bacterial

Levitra (Vardenafil, BAY38-9456)

Phase 3

Erectile Dysfunction

Estradiol valerate, Dienogest (Natazia, Qlaira, BAY86-5027)

Phase 3

Primary Dysmenorrhea

EV/DNG (Qlaira, Natazia, BAY86-5027)

Phase 3

Metrorrhagia

Radium-223 dichloride (BAY88-8223)

Phase 3

Prostatic Neoplasms

Clotrimazole, vaginal ovule

Phase 3

Clotrimazole

LNG-IUS (BAY 86-5028)

Phase 3

Contraception

Gadoteridol (ProHance)

Phase 3

Diagnostic Imaging

Unfractionated heparin

Phase 3

Deep Vein Thrombosis

Nifedipine GITS/Candesartan Cilexetil FDC(BAY98-7106)

Phase 3

Hypertension

Recombinant Factor VIII (Kovaltry, BAY81-8973)

Phase 3

Haemophilia A

Tedizolid (BAY119-2631)

Phase 3

Bacterial Infections

Skyla (Levonorgestrel, BAY86-5028)

Phase 3

Contraception

Avelox (Moxifloxacin, BAY12-8039)

Phase 3

Infectious Diseases

BAY86-6150

Phase 3

Hemophilia A, Hemophilia B

Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)

Phase 3

Macular Edema

VEGF Trap-Eye (BAY86-5321)

Phase 3

Myopia, Pathological

Molidustat (BAY85-3934)

Phase 3

Anemia

Angeliq (Drospirenone/17ß-estradiol, BAY86-4891)

Phase 3

Vasomotor Symptoms

Gemcitabine

Phase 3

Carcinoma, Non-Small-Cell Lung

Gadoxetic Acid Disodium (Primovist, BAY86-4873)

Phase 3

Known or Suspected Focal Liver Lesions

Darbepoetin alfa

Phase 3

Anemia

Testogel (Testosterone, BAYV001915)

Phase 3

Androgens (Deficiency)

Minisiston (SH D00342A)

Phase 3

Contraception

Gadoterate meglumine

Phase 3

Contrast Enhancement in Magnetic Resonance Imaging

Omeprazole/sodium bicarbonate

Phase 3

Gastric Acid

Tadalafil

Phase 3

Erectile Dysfunction

Erlotinib (Tarceva)

Phase 3

Carcinoma, Hepatocellular

Acarbose (Glucobay, BAYG5421)

Phase 3

Diabetes Mellitus

Aspirin

Phase 3

Prevention & Control

Darolutamide (BAY1841788, Nubeqa)

Phase 3

Biochemically Recurrent Prostate Cancer

Gynodian® Depot (BAY86-5032)

Phase 3

Hormone Replacement Therapy

Menostar (Estradiol, BAY86-5435)

Phase 3

Osteopenia

Gestodene/EE (FC Patch Low, BAY86-5016)

Phase 3

Contraception

DRSP 3 mg/EE 20 µg (13 cycles)

Phase 3

Dysmenorrhea

Carboplatin/Paclitaxel

Phase 3

Melanoma

Estradiol valerate/Dienogest (Natazia, Qlaira, BAY86-5027)

Phase 3

Metrorrhagia

Ciprofloxacin DPI (BAYQ3939)

Phase 3

Bronchiectasis

Regorafenib (Stivarga, BAY73-4506)

Phase 3

Colorectal Neoplasms

EE20/DRSP(YAZ, BAY86-5300)

Phase 3

Premenstrual Dysphoric Disorder ( PMDD)

Acetylsalicylic acid (Aspirin, BAYE4465) & Lidocain

Phase 3

Common Cold

0.5mg DRSP / 0.5mg E2 (BAY86-4891)

Phase 3

Vasomotor Symptoms

Aflibercept (EYLEA, BAY86-5321)

Phase 3

Glaucoma, Neovascular

Aflibercept High Dose VEGF Trap-Eye (BAY86-5321)

Phase 3

Neovascular Age-Related Macular Degeneration

Levonorgestrel (BAY98-7196)

Phase 3

Contraception

Copanlisib (Aliqopa, BAY80-6946)

Phase 3

Lymphoma,Non-Hodgkin

Acetylsalicylic Acid (Aspirin, BAYE4465)

Phase 3

Common Cold

Dienogest (Visanne, BAY86-5258)

Phase 3

Endometriosis

Asundexian (BAY2433334)

Phase 3

Prevention of Ischemic Stroke

Tedizolid Phosphate (Sivextro, BAY1192631)

Phase 3

Skin Diseases, Infectious

EE20/Drospirenone (YAZ, BAY86-5300)

Phase 3

Acne Vulgaris

Vardenafil ODT (STAXYN, BAY38-9456)

Phase 3

Erectile Dysfunction

Ertapenem intravenous

Phase 3

Infection

Riociguat (Adempas, BAY63-2521)

Phase 3

Hypertension, Pulmonary

Cipro XR (Ciprofloxacin, BAYQ3939)

Phase 3

Urinary Tract Infection

Ofloxacin

Phase 3

Pelvic Inflammatory Disease

EV/DNG (Qlaira, BAY86-5027)

Phase 3

Oral Contraceptive

Recombinant Factor VIII (Kogenate FS, BAY14-2222)

Phase 3

Hemophilia A

Pembrolizumab

Phase 3

Advanced Non-small Cell Lung Cancer

Phenylephrine

Phase 3

Seasonal Allergic Rhinitis

LNG IUS

Phase 3

Menopause

Calcium carbonate

Phase 3

Hyperphosphatemia

Best standard of care (BSoC)

Phase 3

Hormone Refractory Prostate Cancer

Gadobutrol (Gadovist, Gadavist, BAY86-4875)

Phase 3

Coronary Artery Disease

Naproxen sodium and caffeine (BAY2880376)

Phase 3

Postoperative Dental Pain

BAY 59-7939

Phase 3

Pulmonary Embolism

Sulbactam/Ampicillin

Phase 3

Pneumonia, Aspiration

Radium-223 dichloride (Xofigo, BAY88-8223)

Phase 3

Prostatic Neoplasms

rFVIII (BAY81-8973) on demand

Phase 3

Hemophilia A

Levonorgestrel IUS (Mirena, BAY86-5028)

Phase 3

Menorrhagia

Aflibercept (Eylea, BAY 86-5321)

Phase 3

Glaucoma, Neovascular

Butenafine HCl 1% (BAY1896425)

Phase 3

Hypersensitivity

Visudyne

Phase 3

Macular Degeneration

Levofloxacin & Metronidazole

Phase 3

Pelvic Inflammatory Disease

Naproxen Sodium IR (Aleve, BAYH6689)

Phase 3

Pain, Postoperative

Vardenafil (Levitra, BAY38-9456)

Phase 3

Prostatic Hypertrophy, Benign

Regorafenib (BAY73-4506)

Phase 3

Colorectal Neoplasms

Acyclovir 50mg buccal/topical tablet, BAYM008894/UI1614773

Phase 3

Recurrent Herpes Labialis

Phenylephrine Hydrochloride (HCl) Extended-Release tablets 30 mg

Phase 3

Blood Pressure

Vasovist (BAY86-5283, MS-325)

Phase 3

Peripheral Vascular Diseases

BAY86-5016, SH P00331F

Phase 3

Contraception

Recombinant Factor VIII (BAY81-8973)

Phase 3

Blood Coagulation Disorders

BAY3723113

Phase 3

Obstructive Hypertrophic Cardiomyopathy

BAY2927088

Phase 3

Advanced Solid Tumors

Trasylol (Aprotinin, BAYA0128)

Phase 3

Blood Loss, Surgical

Visanne (BAY86-5258, SH T00660AA)

Phase 3

Endometriosis

Interferon beta-1b (Betaferon/Betaseron, BAY86-5046)

Phase 3

Multiple Sclerosis, Relapsing-Remitting

Ciprofloxacin (BAYO9867)

Phase 3

Burns

Drospirenone/Ethinylestradiol/Methyltetrahydrofolate

Phase 3

Neural Tube Defects

Levonorgestrel IUD (LCS, BAY86-5028)

Phase 3

Contraception

Bifonazole cream 1%

Phase 3

Onychomycosis

Valette

Phase 3

Acne Vulgaris

BAY1841788 / darolutamide (ODM-201)

Phase 3

Metastatic Hormone-sensitive Prostate Cancer

Medroxyprogesterone acetate

Phase 3

Endometrial Hyperplasia

Nifedipine (Adalat, BAYA1040)

Phase 3

Hypertension

Lanthanum Carbonate (BAY77-1931)

Phase 3

Hyperphosphatemia

Levonorgestrel IUS (LCS, BAY86-5028)

Phase 3

Contraception

LCS12

Phase 3

Contraception

Yasmin (30 µg EE, 3 mg Drospirenone, BAY86-5131)

Phase 3

Healthy

Butenafine HCl 1% (BAY1896425) - Induction Phase

Phase 3

Dermatitis, Photoallergic

Ethinylestradiol/Gestodene (BAY86-5016)

Phase 3

Contraception

Testosterone undecanoate (TU) - NebidoTM

Phase 3

Hypogonadism

Aspirin (Acetylsalicylic acid, BAYE4465)

Phase 3

Moderate Risk of CVD

Riociguat (BAY63-2521)

Phase 3

Hypertension, Pulmonary

Yasmin 20

Phase 3

Contraception

Iopromide 370 mg I/mL

Phase 3

Computed Tomography

Best supportive care

Phase 3

Gastrointestinal Stromal Tumors

Positive Control-Sodium lauryl sulfate (SLS)

Phase 3

Hypersensitivity

Ortho Tri Cyclen Lo

Phase 3

Contraception

Advil

Phase 3

Pain

Iloprost (Ventavis inhaled, BAYQ6256)

Phase 3

Hypertension, Pulmonary

Gadopentetate dimeglumine (Magnevist, BAY86-6661)

Phase 3

Magnetic Resonance Imaging

STW5 (Iberogast, BAY98-7411)

Phase 3

Irritable Bowel Syndrome

Phenylephrine HCl (Sinus Comfort, BAY112476)

Phase 3

Nasal Congestion Due to Allergic Rhinitis

Flexible (extended) treatment of EE20/DRSP (YAZ, BAY86-5300)

Phase 3

Contraception

Kogenate (BAY14-2222)

Phase 3

Hemophilia

Abiraterone

Phase 3

Prostatic Neoplasms

EE20/DRSP (BAY86-5300)

Phase 3

Contraception

Vitamin K antagonist (VKA)

Phase 3

Atrial Fibrillation

Phenylephrine Hydrochloride (HCl) Extended Release (ER) Tablets 30 mg

Phase 3

Vasomotor Rhinitis

Ceftriaxone + Metronidazole

Phase 3

Infection, Intra-abdominal

Levofloxacin + Ceftriaxone

Phase 3

Pneumonia

8 mg aflibercept (BAY 86-5321) (High Dose)

Phase 3

Diabetic Macular Edema

Ciprofloxacin

Phase 3

Infectious Diseases

Gestodene/EE Patch (BAY86-5016)

Phase 3

Contraception

SH T04740B

Phase 3

Dysmenorrhea

Naproxen Sodium 440 mg / DPH 25 mg (BAY98-7111)

Phase 3

Pain, Postoperative

Visanne (SH T00660AA , BAY86-5258)

Phase 3

Endometriosis

EV/DNG (Qlaira, BAY86-5027, SH T00658K)

Phase 3

Contraception

Menostar (estradiol transdermal delivery system)

Phase 3

Hot Flashes

Aflibercept Injection (EYLEA, VEGF Trap-Eye, BAY86-5321)

Phase 3

Retinal Vein Occlusion

Fosrenol (Lanthanum Carbonate, BAY77-1931)

Phase 3

Hyperphosphatemia

Azelastine hydrochloride (BAYR9258)

Phase 3

Allergic Rhinitis

Warfarin

Phase 3

Atrial Fibrillation

Levonorgestrel (Kyleena, BAY86-5028)

Phase 3

Contraception

EE20/DRSP/L-5-MTHF (Beyaz, BAY98-7071)

Phase 3

Contraception

Valette (Dienogest/EE30, BAY86-5038)

Phase 3

Oral Contraceptive

BAY86-5300

Phase 3

Contraception

Capecitabine

Phase 3

Breast Cancer

Ertapenem

Phase 3

Intraabdominal Infections

Naproxen sodium 440 mg/DPH 50 mg (BAY98-7111)

Phase 3

Pain

0.5mg NETA / 1.0mg E2 (Activella)

Phase 3

Postmenopause

Copanlisib (BAY 80-6946)

Phase 3

Lymphoma, Non-Hodgkin

Enoxaparin overlapping with and followed by VKA

Phase 3

Pulmonary Embolism

Regorafenib (Stivarga, BAY73- 4506)

Phase 3

Colorectal Neoplasms

EE20/DRSP (YAZ, BAY86-5300)

Phase 3

Oral Contraceptive

Acetylsalicylic Acid (Aspirin Complex, BAYE4465) + Pseudoephedrine

Phase 3

Common Cold

Acetylsalicyclic acid (Fast acting Aspirin, BAY1019036)

Phase 3

Drugs, Investigational

Gadoquatrane (BAY1747846)

Phase 3

Contrast Enhancement in Magnetic Resonance Imaging

Laif® 900, BAY98-7108

Phase 3

Moderate Depressive Episodes (Major Depression)

omeprazole magnesium (20 mg equivalent)

Phase 3

Gastric Acid

Ciprofloxacin (Cipro, BAYQ3939)

Phase 3

Pneumonia

Naproxen Sodium ER (BAYH6689)

Phase 3

Pain

Gadobutrol

Phase 3

Contrast Enhancement in Magnetic Resonance Imaging

Standard of Care

Phase 3

Venous Thromboembolism

Zevalin ([90]Y-ibritumomab tiuxetan, BAY86-5128)

Phase 3

Lymphoma, Non-Hodgkin

Estradiol/DRSP (Angeliq, BAY86-4891)

Phase 3

Vasomotor Symptoms

Zegerid

Phase 3

Intragastric Acidity

Ibuprofen

Phase 3

Low Back Pain

Acetylsalicylic acid (Fast release Aspirin, BAY1019036)

Phase 3

Drugs, Investigational

Magnevist (SH L 451A)

Phase 3

Brain Neoplasms

Interferon beta-1b (Betaseron, BAY86-5046)

Phase 3

Multiple Sclerosis

Magnevist

Phase 3

Central Nervous System Diseases

Moxifloxacin (Avelox, BAY12-8039)

Phase 3

Abscess

Naproxen sodium 440 mg / DPH 50 mg (BAY98-7111)

Phase 3

Pain, Postoperative

YAZ (SH T00186, BAY86-5300)

Phase 3

Contraception

Darolutamide (Nubeqa, BAY1841788)

Phase 3

Prostatic Neoplasms

Ranibizumab

Phase 3

Macular Degeneration

Nifurtimox (Lampit, BAYA2502)

Phase 3

Chagas Disease

ProHance

Phase 3

Brain Metastases

Prevacid®

Phase 3

Human Experimentation

SH D 593 B (Miranova)

Phase 3

Contraception

Ethinylestradiol/Gestodene (FC Patch Low BAY86-5016)

Phase 3

Contraception

Ciprofloxacin (BAYQ3939) dry powder for inhalation

Phase 3

Bronchiectasis

Acarbose

Phase 3

Diabetes Mellitus, Type 2

Sunscreen Test Code: V53-028

Phase 3

Sun Protection

Eylea (Aflibercept, BAY86-5321)

Phase 3

Retinopathy of Prematurity (ROP)

Ciprofloxacin single dose

Phase 3

Bacterial Infections

Drug: YAZ flex (SH T00186D)

Phase 3

Primary Dysmenorrhea

Ceftriaxone; Azithromycin; Amoxicilline/clavulanate; Clarithromycin

Phase 3

Pneumonia

Gadobutrol (Gadovist, BAY86-4875)

Phase 3

Magnetic Resonance Imaging

Finerenone (BAY94-8862)

Phase 3

Chronic Kidney Disease

Sorafenib (Nexavar, BAY43-9006)

Phase 3

Carcinoma, Renal Cell

Yasmin

Phase 3

Contraception

Nexavar (Sorafenib, BAY43-9006)

Phase 3

Carcinoma, Renal Cell

Interferon beta-1b

Phase 3

HIV Infections

BAY94-9027

Phase 3

Hemophilia A

Enoxaparin

Phase 3

Venous Thromboembolism

Rivaroxaban (BAY59-7939)

Phase 3

Venous Thromboembolism

Aflibercept, VEGF Trap-Eye(Eylea, BAY86-5321)_higher dose

Phase 3

Macular Edema Secondary to Retinal Vein Occlusion

Gadopentetate dimeglumine (Magnevist)

Phase 3

Cardiovascular Abnormalities

Gadopentetate dimeglumine (Magnevist, BAY86-4882)

Phase 3

Peripheral Vascular Disease

Ventavis (Iloprost, BAYQ6256)

Phase 3

Hypertension, Pulmonary

Rivaroxaban (Xarelto, BAY59-7939)

Phase 3

Pulmonary Embolism

D,L-lysine acetylsalicylate (Aspirin, BAY81-8781) 500 mg IV

Phase 3

Acute Coronary Syndrome

EE20/DRSP(BAY86-5300)

Phase 3

Endometriosis

Acetylsalicyclic acid (Fast release Aspirin, BAY1019036)

Phase 3

Healthy Subjects

Elinzanetant (BAY3427080)

Phase 3

Vasomotor Symptoms Associated With Menopause

YAZ (DRSP 3 mg/EE 0.02 mg, BAY86-5300)

Phase 3

Contraception

Rogaratinib (BAY1163877)

Phase 3

Carcinoma, Transitional Cell

EV/DNG (Qlaira, BAY86-5027, SH T00658ID)

Phase 3

Contraception

Damoctocog alfa pegol (Jivi, BAY94-9027)

Phase 3

Treatment of Bleeding

Finerenone

Phase 3

Chronic Kidney Disease

Enoxaparin followed by VKA

Phase 3

Venous Thrombosis

Darbepoetin

Phase 2

Anemia

Naproxen gel

Phase 2

Soft Tissue Injury

Amikacin (BAY41-6551)

Phase 2

Pneumonia

BAY94-8862

Phase 2

Diabetic Nephropathies

Radium-223 chloride (BAY88-8223)

Phase 2

Breast Cancer

Interferon

Phase 2

Carcinoma, Renal Cell

BAY 3713372

Phase 2

MTAP-deleted Solid Tumors

BAY 77-1931

Phase 2

Hyperphosphatemia

RDEA119

Phase 2

Advanced Cancer

Spironolactone

Phase 2

Heart Failure

Sagopilone 16 mg/m^2 i.v., Acetyl-L-Carnitine (ALC) 1000 mg tid, HRPC only: Prednisone or Prednisolone 5 mg bid

Phase 2

Prostate Cancer

Vilaprisan (BAY1002670)

Phase 2

Leiomyoma

BAY 86-5310 (ZK 283197)

Phase 2

Vasomotor System

Gadobutrol~0.03 mmol/kg BW (Gadavist, Gadovist, BAY86-4875)

Phase 2

Brain Diseases

Anetumab ravtansine (BAY94-9343)

Phase 2

Mesothelioma

BAY1067197 (treatment 2)

Phase 2

Heart Failure

(LMW) Heparin + Vitamin K Antagonist

Phase 2

Venous Thromboembolism

Rivaroxaban, (BAY59-7939)

Phase 2

Venous Thromboembolism

SH D01155E

Phase 2

Pregnancy, Unplanned

Taxane (Cytotoxic, BAY59-8862)

Phase 2

Lymphoma, Non-Hodgkin

Ciprofloxacin (Cipro Inhale, BAYQ3939)

Phase 2

Cystic Fibrosis

Naproxen sodium/Caffeine (BAY2880376)

Phase 2

Pain, Postoperative

Molidustat (BAY 85-3934)

Phase 2

Anemia

BAY2395840

Phase 2

Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

Interleukin-2 SA

Phase 2

HIV Infections

Candesartan cilexetil (Atacand), 4 mg

Phase 2

Hypertension, Essential

Drospirenone/17ß-estradiol (Angeliq, BAY86-4891)

Phase 2

Postmenopause

BAY 3401016

Phase 2

Alport Syndrome

BAY2927088_formulation A

Phase 2

Advanced Non-small Cell Lung Cancer

Vericiguat (BAY1021189) 2.5 mg, 5 mg or 10 mg IR tablets

Phase 2

Chronic Heart Failure With Preserved Ejection Fraction

BAY3427080

Phase 2

Post-menopausal Vasomotor Symptoms

Levonorgestrel

Phase 2

Endometriosis

Dexpanthenol foam spray, new formulation

Phase 2

Skin Abnormalities

Epoetin alfa/beta

Phase 2

Anemia

SH T04769G

Phase 2

Oral Contraceptive

PEG 3350 laxative plus electrolytes (PEG + E)/Macrogol (Movicol®, BAY81-8430)

Phase 2

Constipation

Riociguat (Adempas, BAY63-2521).

Phase 2

Hypertension, Pulmonary

Oxymetazoline HCl 0.05% nasal gel

Phase 2

Nasal Congestion

Sagopilone (ZK 219477) + prednisone

Phase 2

Prostate Cancer

Regorafenib, (Stivarga, BAY73-4506)

Phase 2

Solid Tumors

Sorafenib (Nexavar, BAY43-9006) plus Doxorubicin

Phase 2

Carcinoma, Hepatocellular

Copanlisib (BAY80-6946)

Phase 2

Lymphoma Non-Hodgkin

Betaseron (Interferon beta-1b, BAY86-5046)

Phase 2

Multiple Sclerosis

alemtuzumab

Phase 2

Leukemia

Asoprisnil (BAY86-5294)

Phase 2

Menorrhagia

Bay 59-8862

Phase 2

Carcinoma, Renal Cell

BAY2599023 (DTX201)

Phase 2

Hemophilia A

BAY85-3934

Phase 2

Anemia

BAY86-9766 MEK Inhibitor + Sorafenib

Phase 2

Carcinoma, Hepatocellular

BAY86-9766+Gemcitabine

Phase 2

Pancreatic Neoplasms

BAY1902607

Phase 2

Cough

Sagopilone (ZK 219477)

Phase 2

Breast Neoplasm

Zevalin (SH L 749 , BAY86-5128)

Phase 2

Non-Hodgkin's Lymphoma

Darolutamide

Phase 2

High-Risk Localized Prostate Cancer

STW5 (Iberogast®, BAY98-7411)

Phase 2

Functional Gastrointestinal Disorders

Cisplatin

Phase 2

Carcinoma, Small Cell

BAY1067197 (10 mg)

Phase 2

Heart Failure

Zabedosertib (BAY1834845)

Phase 2

Atopic Dermatitis

Piroxicam ( BAYl1902)

Phase 2

Contraception, Postcoital

ZK245186

Phase 2

Atopic Dermatitis

runcaciguat

Phase 2

Chronic Kidney Disease

Sorafenib (Nexavar, BAY43-9006) + mFOLFOX6 (5-FU, levo-leucovorin, oxaliplatin)

Phase 2

Metastatic Colorectal Cancer

E2/DRSP (BAY 86-4891) dose 1 (SH T04984E)

Phase 2

Contraceptive, Oral, Hormonal

Enoxaparin/Vitamin K-Antagonist

Phase 2

Venous Thrombosis

BAY86-4891 (Estradiol / Drospirenone)

Phase 2

Contraception

BAY3018250

Phase 2

Thrombolysis

Runcaciguat (BAY1101042)

Phase 2

Diabetic Retinopathy

Yasminelle (SH T 00186 D)

Phase 2

Contraceptives, Oral

Gadobutrol (Gadavist,Gadovist, BAY86-4875)

Phase 2

Myocardial Perfusion Imaging

BAY 1753011

Phase 2

Heart Failure (HF)

BAY2433334

Phase 2

Atrial Fibrillation (AF)

BAY2586116

Phase 2

Sleep Apnea, Obstructive

Exemestane

Phase 2

Breast Neoplasms

Sagopilone (BAY86-5302 , ZK219477)

Phase 2

Ovarian Neoplasms

Sagopilone (BAY86-5302, ZK 219477)

Phase 2

Breast Neoplasms

Darolutamide 600 mg twice daily

Phase 2

Prostate Cancer

Histone Deacetylase Inhibitor, MS-275 (BAY 86-5274, ZK 244894)

Phase 2

Melanoma

BAY1002670

Phase 2

Leiomyoma

Fulacimstat (BAY1142524)

Phase 2

Myocardial Infarction

Repinotan HCl (BAYX3702)

Phase 2

Stroke

BAY1193397

Phase 2

Diabetic Foot

BAY2586116 (A1)

Phase 2

Sleep Apnea, Obstructive

Combination drug

Phase 2

Cancer

BAY85-8501

Phase 2

Bronchiectasis

Neladenoson bialanate (BAY1067197)

Phase 2

Heart Failure

Vericiguat (BAY1021189) (5 mg)

Phase 2

Heart Failure

Phenylephrine HCl

Phase 2

Rhinitis

Levonorgestrel IUS (BAY86-5028, G04209B)

Phase 2

Contraception

BAY59-8862 (Cytotoxic Taxane)

Phase 2

Carcinoma, Non-Small-Cell Lung

Dehydroepiandrosterone, BAY86-5314

Phase 2

Libido

BAY1213790 (Osocimab)

Phase 2

End-stage Renal Disease

Nifedipine (Adalat CR, BAYA1040) 80mg OD

Phase 2

Hypertension

SH T00268C

Phase 2

Non Small Cell Lung Cancer

Eplerenone

Phase 2

Heart Failure

Dexpanthenol foam spray, old formulation

Phase 2

Erythema

Polyethylene Glycol (PEG 3350)

Phase 2

Constipation

BAY2253651

Phase 2

Sleep Apnea, Obstructive

UFH

Phase 2

Cardiovascular Disease

Hydrocortison cream

Phase 2

Atopic Dermatitis

BAY3283142

Phase 2

Chronic Kidney Disease

BAY60-4552 plus Vardenafil

Phase 2

Erectile Dysfunction

Finerenone (BAY94-8862 ) 10 mg

Phase 2

Type 2 Diabetes Mellitus

Sildenafil

Phase 2

Pulmonary Hypertension

Larotrectinib (Vitrakvi, BAY2757556)

Phase 2

Solid Tumors Harboring NTRK Fusion

Mapracorat

Phase 2

Atopic Dermatitis

Sorafenib (BAY43-9006)

Phase 2

Carcinoma, Hepatocellular

Docetaxel

Phase 2

Bone Metastases

Magnevist (Gadopentetate dimeglumine, BAY86-4882)

Phase 2

Myocardial Infarction

Vericiguat (BAY1021189) 5 mg

Phase 2

Chronic Heart Failure With Reduced Ejection Fraction

Darolutamide(BAY1841788, Nubeqa)

Phase 2

Biochemically Recurrent Prostate Cancer

Gadobutrol (Gadovist/Gadavist)

Phase 2

Central Nervous System Pathology

Vardenafil HCl (Levitra, BAY38-9456)

Phase 2

Overactive Bladder

Dacarbazine

Phase 2

Cancer

Interferon beta 1b (Betaseron, BAY86-5046)

Phase 2

Multiple Sclerosis, Relapsing-Remitting

Capadenoson (BAY68-4986)

Phase 2

Atrial Fibrillation

Ethinylestradiol/Gestogene (BAY86-5016)

Phase 2

Contraception

Xarelto (Rivaroxaban, BAY59-7939)

Phase 2

Atrial Fibrillation

Sagopilone (ZK 219477) + carboplatin

Phase 2

Ovarian Neoplasms

Bifonazole spray once daily

Phase 2

Tinea Pedis

CCR1-Antagonist (BAY86-5047, ZK811752)

Phase 2

Endometriosis

Sorafenib (Nexavar,BAY43-9006)

Phase 2

Thyroid Carcinoma

Lonaprisan (ZK 230211, BAY86-5044)

Phase 2

Metastatic Breast Cancer

Elinzanetant

Phase 2

Sleep Disturbances Associated With Menopause

BAY98-7443

Phase 2

Contraception

BAY73-4506 (Regorafenib, Stivarga)

Phase 2

Solid Cancer

Fesomersen sodium (BAY2976217)

Phase 2

End Stage Renal Disease Requiring Hemodialysis

BAY1817080

Phase 2

Overactive Bladder

Sorafenib (Nexavar, BAY43-9006) + Dacarbazine (DTIC)

Phase 2

Melanoma

EV/DNG (SH T00658L)

Phase 2

Ovulation Inhibition

BAY2757556 (Larotrectinib, Vitrakvi)

Phase 2

Solid Tumors Harboring NTRK Fusion

Vericiguat (BAY1021189) (1.25 mg)

Phase 2

Heart Failure

BAY73-4506

Phase 2

Carcinoma, Hepatocellular

Gadopentetate dimeglumine (Magnevist, BAY86-4882, SH L 451A)

Phase 2

Magnetic Resonance Angiography

Naproxen Sodium (Aleve, BAY117031)

Phase 2

Osteoarthritis, Knee

ZK 245186

Phase 2

Atopic Dermatitis

Nivolumab (Opdivo)

Phase 2

Colorectal Cancer

Active comparator

Phase 2

Venous Thrombosis

Refametinib (BAY86-9766)

Phase 2

Carcinoma, Hepatocellular

Apixaban

Phase 2

Knee Arthroplasty, Total

Abiraterone acetate

Phase 2

Prostatic Neoplasms

BAY1142524

Phase 2

Heart Failure

lloprost(Ventavis,BAYQ6252, 20 µg/mL)

Phase 2

Pulmonary Arterial Hypertension

Inspra (eplerenone)

Phase 2

Heart Failure

Market-Implied Move
Regulatory Approvals

Frequently asked questions

What is in BAYER's drug pipeline?

CatalystAlert tracks 350 drug candidates in BAYER's (BAYRY) pipeline across Phase 3, Phase 2. Its lead program is Gadobutrol (Gadavist, Gadovist, BAY86-4875) (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is BAYER's next FDA catalyst?

BAYER's (BAYRY) next tracked catalyst is a Phase 3 expected August 31, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track BAYRY biotech catalysts?

Add BAYRY to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow BAYER's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply